AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease

AHR 2016：芳烃受体作为健康和疾病的中心介质

• 批准号: 9121735
• 负责人: B Paige Lawrence
• 金额: $ 1万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9121735
• 关键词: Address; Applied Research; Area; Aryl Hydrocarbon Receptor; Attention; Basic Science; Biological Process; Clinical; Clinical Medicine; Collaborations; Communities; Consensus; Development; Developmental Biology; Disabled Persons; Disadvantaged; Discipline; Disease; Doctor of Philosophy; Ensure; Environmental Health; Environmental Medicine; Environmental Pollution; Fertilization; Fostering; Foundations; Funding; Future; Germany; Goals; Grant; Health; Human; Immunology; Interdisciplinary Communication; International; Knowledge; Ligands; Mediator of activation protein; Minority; Minority Groups; Molecular; National Institute of Environmental Health Sciences; Oral; Output; Participant; Personal Satisfaction; Pharmacology; Pharmacy (field); Postdoctoral Fellow; Public Health; Publishing; Regulation; Request for Applications; Research; Research Personnel; Research Priority; Role; Science; Scientist; Source; Students; Thinking; Toxic effect; Toxicology; Universities; Woman; abstracting; aryl hydrocarbon receptor ligand; base; improved; interest; meetings; multidisciplinary; posters; prevent; programs; public health relevance; rapid growth; symposium; translational approach

 DESCRIPTION (provided by applicant): This application requests funds to support an international conference entitled "AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease" which will be in Rochester, NY in August 3-6, 2016. Specifically, funds from this R13 application to the NIEHS will be used to support disadvantaged poorly represented and/or junior investigators who submit research abstracts and wish to participate in the meeting, but who otherwise might not be able to attend. Their participation will undoubtedly strengthen the conference and the field as a whole. This conference covers a topic that is highly relevant to toxicology and environmental health sciences, and which is also gaining tremendous attention from other sectors, including basic immunology, developmental biology, pharmacology, and pharmaceutics. However, there are no regular (or as far as we know, planned) scientific conferences focused solely on the AHR. Given the rapid but poorly integrated advancements in the field, there is pressing need to bring together toxicologists, basic biologists, and clinical/translational researchers who are all interested in the AHR and its many ligands? Therefore, in addition to fostering the participation of junior investigators, women, minority groups, and the disabled, other goals of this conference include the following: promoting greater interactions among scientists of diverse backgrounds; creating the opportunity to discuss cutting-edge science, and building the foundation for cross- disciplinary communication and collaborations to advance the field. This conference will advance the pace of science by identifying key knowledge gaps and developing strategies to address them, pinpointing critical implications for environmental health and clinical medicine, and building consensus for addressing specific research priorities that relate to these issues. As a consequence of these goals, the meeting is expected to promulgate cutting-edge information that will catalyze new discoveries to improve health and well-being. Also, as a more tangible output, the Organizing Committee plans to develop a review article to be submitted after this conference. Based upon meeting attendance, presentations, and discussion, the organizers will assess the potential for a more expanded set of research and/or review articles based on this conference, as well as evaluate the potential for a future conference on this topic.

 描述（由申请人提供）：本申请请求资金支持题为“AHR 2016：芳基碳氢化合物受体作为健康和疾病的中央调节剂”的国际会议，该会议将于 2016 年 8 月 3 日至 6 日在纽约州罗切斯特举行。具体来说，向 NIEHS 提交的 R13 申请的资金将用于支持提交研究摘要并希望参加会议的弱势群体和/或初级研究人员， 但否则谁可能无法参加。他们的参与无疑将加强会议和整个领域的力量。本次会议涵盖的主题与毒理学和环境健康科学高度相关，也引起了基础免疫学、发育生物学、药理学和药剂学等其他领域的极大关注。然而，没有定期的（或据我们所知，计划中的）科学会议仅关注 AHR。鉴于该领域进展迅速但整合程度较差，迫切需要将对 AHR 及其众多配体感兴趣的毒理学家、基础生物学家和临床/转化研究人员聚集在一起？因此，除了促进初级研究者、女性、少数群体和残疾人的参与外，本次会议的其他目标还包括：促进不同背景的科学家之间更多的互动；创造讨论尖端科学的机会，并为跨学科交流与合作奠定基础，以推动该领域的发展。本次会议将通过确定关键知识差距并制定解决这些问题的战略、查明对环境健康和临床医学的关键影响以及就解决与这些问题相关的具体研究重点达成共识来推进科学的步伐。作为这些目标的结果，会议预计将公布前沿信息，从而促进新发现，以改善健康和福祉。此外，作为更具体的成果，组委会计划编写一篇评论文章，并在本次会议后提交。根据会议出席情况、演讲和讨论，组织者将评估基于本次会议的更广泛的研究和/或评论文章的潜力，以及评估未来关于该主题的会议的潜力。